Because early detection offers the best chance of surviving cancer, screening tests that involve one quick blood draw are generating excitement. If approved, rather than scheduling downtime and facing intimidating procedures, patients could undergo screening for multiple cancers at once, just by rolling up their sleeves during routine doctor exams.
LOUISVILLE, Colo., July 24, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the second quarter ended June 30, 2025 after the […]
The Boettcher Foundation has selected eight researchers, including three from the University of Colorado Anschutz Medical Campus, to receive funding through the Boettcher Foundation’s Webb-Waring Biomedical Research Awards program. Click here to view original post
AURORA, Colo., Sept. 27, 2022 /PRNewswire/ — Foresight Diagnostics, Inc, a leader in cancer diagnostics and cancer relapse testing, announced today that the U.S. Patent and Trademark Office (USPTO) has granted the company patent No.11,447,833 […]
Copyright © 2026 Biotech Networks
